Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Convertible Debt (2019 - 2023)

Historic Convertible Debt for Ocular Therapeutix (OCUL) over the last 5 years, with Q4 2023 value amounting to $9.1 million.

  • Ocular Therapeutix's Convertible Debt fell 6821.45% to $9.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $9.1 million, marking a year-over-year decrease of 6821.45%. This contributed to the annual value of $9.1 million for FY2023, which is 6821.45% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Convertible Debt of $9.1 million as of Q4 2023, which was down 6821.45% from $8.8 million recorded in Q3 2023.
  • In the past 5 years, Ocular Therapeutix's Convertible Debt registered a high of $30.0 million during Q2 2023, and its lowest value of $8.8 million during Q3 2023.
  • Its 5-year average for Convertible Debt is $24.3 million, with a median of $25.3 million in 2020.
  • As far as peak fluctuations go, Ocular Therapeutix's Convertible Debt soared by 1026.86% in 2020, and later tumbled by 6886.54% in 2023.
  • Over the past 5 years, Ocular Therapeutix's Convertible Debt (Quarter) stood at $24.3 million in 2019, then grew by 0.01% to $24.3 million in 2020, then increased by 8.75% to $26.4 million in 2021, then increased by 8.75% to $28.7 million in 2022, then tumbled by 68.21% to $9.1 million in 2023.
  • Its Convertible Debt was $9.1 million in Q4 2023, compared to $8.8 million in Q3 2023 and $30.0 million in Q2 2023.